Frovocimab Uses, Dosage, Side Effects and more
Frovocimab is under investigation in clinical trial NCT01671085 (A Study of LY3015014 in Healthy Participants With High Cholesterol).
| Trade Name | Frovocimab |
| Generic | Frovocimab |
| Frovocimab Other Names | Frovocimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
